In this video from ASM 2016, Amanda Paschke, MD, of Merck, and Infectious Disease Advisor’s Michael Tapper, MD, discuss the importance of developing new medications, particularly for sepsis.

Dr Paschke explains that there is an urgent need for new drugs, and that it is important to have more than one option available to treat a wide spectrum of resistance mechanisms.